DTSRF yields 75.47% · JNJ yields 2.14%● Live data
📍 DTSRF pulled ahead of the other in Year 1
Combined, DTSRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTSRF + JNJ for your $10,000?
The fund invests directly in ether that are held securely in cold storage while seeking to benefit from staking. Staking refers to the proof-of-stake consensus protocols that ensure transactions are properly recorded on a blockchain. The process allows owners of a cryptocurrency to validate block transactions through validators that verify the accuracy of recorded data. In return, validators are rewarded with digital assets. For the fund, rewards are paid in ether and will depend on the amount of ether staked. Staked ether serve as collateral that are locked in the network but are at risk of loss if validators fail to meet network rules. The fund manager selects and directs experienced sub-custodians as validators for staking activities. In addition, the fund manager has discretion in the amount of staked ether from the portfolio. The ETF does not intend to use derivatives or employ leverage to acquire ether. It may also hold cash, cash equivalents or other money market instruments.
Full DTSRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.